Answers are grounded in this paper and cite their sources.
NarrativeDesmopressin (DDAVP) is a synthetic analog of vasopressin that stimulates the release of von Willebrand factor and promotes platelet adhesion and aggregation and is therefore typically used for the treatment of von Willebrand disease and hemophilia [1][2][3] .Some professional societies, however, recommend perioperative DDAVP for the prevention of blood loss and blood product transfusion in patients with bleeding and platelet dysfunction [4][5][6] .
No takes yet. Share an insight, caveat, or question.
Long et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: